Basilar Type Migraine - Explore the Science & Experts | ideXlab

Scan Science and Technology

Contact Leading Edge Experts & Companies

Basilar Type Migraine

The Experts below are selected from a list of 204 Experts worldwide ranked by ideXlab platform

Jiying Zhou – 1st expert on this subject based on the ideXlab platform

  • HEADACHE & FACIAL PAIN SECTION Original Research Article Clinical Characteristics of BasilarType Migraine in the Neurological Clinic of a University Hospital
    , 2016
    Co-Authors: Guomin Ying, Nan Li, Jing Wang, Wangwen Li, Jiying Zhou

    Abstract:

    eral visual symptoms 39%, hypacusia 26%, ataxia 26%, dysarthria 22%, bilateral paresthesias 13%, and decreased level of consciousness 13%. Intense emotional stimuli (74%) and sleep disorders (65%) were the most common trigger factors, followed by change in weather, sunshine, cold wind, acute stress, alcohol, and fatigue. Conclusion. BasilarType Migraine is an episodic disorder and occurred in 1.5% of patients with headache. More than one-half of patients have their first attack in the second and third decade of life. Trigger factors were common, and patients should be educated to avoid trigger factors.

  • headache facial pain section original research article clinical characteristics of Basilar Type Migraine in the neurological clinic of a university hospital
    , 2016
    Co-Authors: Guomin Ying, Nan Li, Jing Wang, Wangwen Li, Jiying Zhou

    Abstract:

    eral visual symptoms 39%, hypacusia 26%, ataxia 26%, dysarthria 22%, bilateral paresthesias 13%, and decreased level of consciousness 13%. Intense emotional stimuli (74%) and sleep disorders (65%) were the most common trigger factors, followed by change in weather, sunshine, cold wind, acute stress, alcohol, and fatigue. Conclusion. BasilarType Migraine is an episodic disorder and occurred in 1.5% of patients with headache. More than one-half of patients have their first attack in the second and third decade of life. Trigger factors were common, and patients should be educated to avoid trigger factors.

  • neuropathic pain section case report Basilar Type Migraine with coma case reports and literature review
    , 2016
    Co-Authors: Qin Li, Jiying Zhou

    Abstract:

    Background. BasilarType Migraine (BTM) is a rare subType of Migraine with aura. Impaired conscious- ness or coma can occur in such patients. Aim. To report two Chinese adolescent patients diagnosed as BTM with coma. Materials and Methods. We describe two Chinese adolescent patients diagnosed with BTM with coma. Literatures of Migraineurs presented with coma were reviewed. Results. The two patients are partially resolved with prophylactic propranolol or valproate therapy. Conclusion. BTM should be considered for any patient presenting with Migraine and coma. Adequate care should be taken to prevent Migraine attacks.

Matthew S Robbins – 2nd expert on this subject based on the ideXlab platform

  • pontine infarction as a complication of Basilar Type Migraine status migrainosus p01 093
    Neurology, 2013
    Co-Authors: Sarah E Vollbracht, Matthew S Robbins, Ilya Kister

    Abstract:

    OBJECTIVE: To present a patient with BasilarType Migraine (BTM) sustaining a pontine infarction during status migrainosus and to discuss the case in the context of the International Classification of Headache Disorders, 2nd Edition (ICHD-2) criteria for migrainous infarction. BACKGROUND: The ICHD-2 defines migrainous infarction as one or more otherwise typical aura symptoms that persist beyond one hour with neuroimaging confirmation of an ischemic infarction in the affected territory. The ICHD-2 criteria exclude patients with new onset aura as well as patients who develop “extra-aural” symptoms at the time of infarction. DESIGN/METHODS: Case report from a tertiary medical center. RESULTS: A 42-year-old woman with BTM whose aura symptoms included vertigo, tinnitus, hypacusis, gait unsteadiness, and disorientation developed her typical constellation of aura symptoms followed by a two-week period of status migrainosus, which she was treating with eletriptan 40 to 80mg mg daily. Several days into the headache phase she experienced acute, maximal-at-onset dysarthria and left face, arm, and leg numbness and weakness. These symptoms minimally improved over several weeks, leaving her with mild residual left-sided sensorimotor deficits and dysarthria. She had also been taking estrogen-containing oral contraception. MRI and MRA of the brain revealed a pontine ischemic lesion and Basilar artery fenestration. CONCLUSIONS: This patient presents a diagnostic dilemma, since her stroke symptoms were not part of her typical aura syndrome and therefore does not fulfill ICHD-2 criteria for migrainous infarction. These restrictions on what constitutes a bona fide migrainous infarction may improve specificity at the expense of sensitivity, potentially underestimating the role of Migraine in stroke etiology. Disclosure: Dr. Vollbracht9s family owns stock and/or stock options in Allergan, Inc. Dr. Robbins has nothing to disclose. Dr. Kister has nothing to disclose.

  • Primary headache disorders and neuro-ophthalmologic manifestations.
    Eye and brain, 2012
    Co-Authors: Daniel Schwartz, Matthew S Robbins

    Abstract:

    Headache is an extraordinarily common complaint presenting to medical practitioners in all arenas and specialties, particularly primary care physicians, neurologists, and ophthalmologists. A wide variety of headache disorders may manifest with a myriad of neuro-ophthalmologic symptoms, including orbital pain, disturbances of vision, aura, photophobia, lacrimation, conjunctival injection, ptosis, and other manifestations. The differential diagnosis in these patients is broad and includes both secondary, or symptomatic, and primary headache disorders. Awareness of the headache patterns and associated symptoms of these various disorders is essential to achieve the correct diagnosis. This paper reviews the primary headache disorders that prominently feature neuro-ophthalmologic manifestations, including Migraine, the trigeminal autonomic cephalalgias, and hemicrania continua. Migraine variants with prominent neuro-ophthalmologic symptoms including aura without headache, BasilarType Migraine, retinal Migraine, and ophthalmoplegic Migraine are also reviewed. This paper focuses particularly on the symptomatology of these primary headache disorders, but also discusses their epidemiology, clinical features, and treatment.

  • cacna1a nonsense mutation is associated with Basilar Type Migraine and episodic ataxia Type 2
    Headache, 2009
    Co-Authors: Matthew S Robbins, Richard B Lipton, Emma Laureta, Brian M Grosberg

    Abstract:

    Mutations in the CACNA1A gene on chromosome 19 have been associated with a variety of clinical disorders, including familial hemiplegic Migraine Type 1 and episodic ataxia Type 2 (EA2). We report a patient with 2 distinct attack Types, one representing EA2 and the other, BasilarType Migraine. Genetic testing revealed a novel nonsense mutation in the CACNA1A gene at codon position 583. Treatment with acetazolamide relieved both Types of attacks. We hypothesize that the CACNA1A gene mutation may contribute to both typical EA2 and typical BasilarType Migraine, extending the spectrum of clinical manifestations associated with CACNA1A mutations.

Brian M Grosberg – 3rd expert on this subject based on the ideXlab platform

  • cacna1a nonsense mutation is associated with Basilar Type Migraine and episodic ataxia Type 2
    Headache, 2009
    Co-Authors: Matthew S Robbins, Richard B Lipton, Emma Laureta, Brian M Grosberg

    Abstract:

    Mutations in the CACNA1A gene on chromosome 19 have been associated with a variety of clinical disorders, including familial hemiplegic Migraine Type 1 and episodic ataxia Type 2 (EA2). We report a patient with 2 distinct attack Types, one representing EA2 and the other, BasilarType Migraine. Genetic testing revealed a novel nonsense mutation in the CACNA1A gene at codon position 583. Treatment with acetazolamide relieved both Types of attacks. We hypothesize that the CACNA1A gene mutation may contribute to both typical EA2 and typical BasilarType Migraine, extending the spectrum of clinical manifestations associated with CACNA1A mutations.

  • CACNA1A Nonsense Mutation is Associated With BasilarType Migraine and Episodic Ataxia Type 2
    Headache, 2009
    Co-Authors: Matthew S Robbins, Richard B Lipton, Emma Laureta, Brian M Grosberg

    Abstract:

    Mutations in the CACNA1A gene on chromosome 19 have been associated with a variety of clinical disorders, including familial hemiplegic Migraine Type 1 and episodic ataxia Type 2 (EA2). We report a patient with 2 distinct attack Types, one representing EA2 and the other, BasilarType Migraine. Genetic testing revealed a novel nonsense mutation in the CACNA1A gene at codon position 583. Treatment with acetazolamide relieved both Types of attacks. We hypothesize that the CACNA1A gene mutation may contribute to both typical EA2 and typical BasilarType Migraine, extending the spectrum of clinical manifestations associated with CACNA1A mutations.

  • brief communications cacna1a nonsense mutation is associated with Basilar Type Migraine and episodic ataxia Type 2
    , 2009
    Co-Authors: Matthew S Robbins, Richard B Lipton, Emma Laureta, Brian M Grosberg

    Abstract:

    Mutations in the CACNA1A gene on chromosome 19 have been associated with a variety of clinical disorders, including familial hemiplegic Migraine Type 1 and episodic ataxia Type 2 (EA2). We report a patient with 2 distinct attack Types, one representing EA2 and the other, BasilarType Migraine. Genetic testing revealed a novel nonsense mutation in the CACNA1A gene at codon position 583. Treatment with acetazolamide relieved both Types of attacks. We hypothesize that the CACNA1A gene mutation may contribute to both typical EA2 and typical BasilarType Migraine, extending the spectrum of clinical manifestations associated with CACNA1A mutations.